Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Evaluating the Rise of HCC & New Risk to Progression: A NAFLD/NASH Case Study

Program Information

Program Information

ReachMD Healthcare Image

Explore why understanding NAFLD/NASH is key to detecting hepatocellular carcinoma through a patient case.

  • Overview

    Rates of hepatocellular carcinoma (HCC) are on the rise in the US, and the fast-growing cause of the disease is non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH).  Understanding the unique factors of patients with NAFLD/NASH is a key component to detecting HCC early. Here to dive into this idea further through the lens of a patient case is Dr. Jeffrey H. Schneider, community gastroenterologist/hepatologist in Coral Springs, Florida.

Schedule20 Oct 2021
Webpack App